Proshrs Ultra Nq Bio (BIB) 45.88 $BIB Biotech Companies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proshrs Ultra Nq Bio (BIB) 45.88 $BIB

Biotech Companies With Huge Potential
ACCESSWIRE - Wed Aug 31, 8:24AM CDT
LAS VEGAS, NV / ACCESSWIRE / August 31, 2016 / Outside of the energy sector, the past year, there has not been any sector under more pressure than biotechnology. As an example of the bearish bias, the ProShares Ultra NASDAQ Biotechnology ETF (NASDAQ: BIB) has slumped from a record high last July at $106.10 to a low of $33.97 late in June, representing a top-to-bottom decline of 68%. For the most part, biotechs of all sizes have felt the pain. Markets are always cyclical and I believe the biotech beat down is reaching its bottom and will soon begin to reverse the trend. From a technical perspective, I think that BIB breaking over $50 again will be a sign of the reversal (it's currently around $43).
BIB: 45.88 (-0.77), GSK: 43.46 (+0.10), OCUL: 6.39 (-0.38)

ProShares Ultra Nasdaq Biotechnology ETF Shares Up 18.3% Since SmarTrend's Buy Recommendation (BIB)
Comtex SmarTrend(R) - Thu Aug 25, 1:05AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on July 6th, 2016 at $40.33. In approximately 2 months, ProShares Ultra Nasdaq Biotechnology ETF has returned 18.31% as of today's recent price of $47.71.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 3.70%
Comtex SmarTrend(R) - Mon Aug 22, 3:23PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $49.66 to a high of $51.32. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $50.02 on volume of 447,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 20.8% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Wed Aug 17, 1:53PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on July 6th, 2016 at $40.33. In approximately 1 month, ProShares Ultra Nasdaq Biotechnology ETF has returned 20.84% as of today's recent price of $48.73.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Rebound After Yesterday's Selloff of 3.22%
Comtex SmarTrend(R) - Wed Aug 10, 2:19PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $48.50 to a high of $50.55. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $50.17 on volume of 721,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Up 21.3% Since SmarTrend Uptrend Call (BIB)
Comtex SmarTrend(R) - Tue Aug 02, 1:45PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on July 6th, 2016 at $40.33. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 21.26% as of today's recent price of $48.90.
BIB: 45.88 (-0.77)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 2.82% Gain
Comtex SmarTrend(R) - Mon Aug 01, 4:10PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $49.09 to a high of $51.45. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $49.04 on volume of 807,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback after Yesterday's 2.99% Rise
Comtex SmarTrend(R) - Tue May 31, 4:52PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $45.54 to a high of $46.80. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $45.15 on volume of 628,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 1.72% Yesterday
Comtex SmarTrend(R) - Fri May 27, 3:22PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $44.03 to a high of $45.14. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $45.10 on volume of 257,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

After Yesterday's Rally of 1.14% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 23, 3:18PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $41.26 to a high of $42.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $41.69 on volume of 446,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.85% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 18, 4:17PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $46.55 to a high of $49.05. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $47.93 on volume of 521,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Pullback After Gaining 4.09% Yesterday
Comtex SmarTrend(R) - Mon Apr 04, 3:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $43.33 to a high of $45.17. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $43.44 on volume of 796,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

New Strong Buy Stocks for April 4th
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 9:14AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
ALGN: 92.90 (-0.29), BIB: 45.88 (-0.77), CNS: 42.13 (-0.46), AKG: 3.77 (-0.02), SFR: 31.00 (+0.48)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 5.95%
Comtex SmarTrend(R) - Thu Mar 31, 2:33PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $39.13 to a high of $41.53. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $41.48 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 45.88 (-0.77)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 33.7% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Feb 05, 5:44PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 33.67% as of today's recent price of $40.16.
BIB: 45.88 (-0.77)

Downtrend Call Working As ProShares Ultra Nasdaq Biotechnology ETF Stock Falls 30.1% (BIB)
Comtex SmarTrend(R) - Fri Jan 29, 5:04PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 3 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 30.07% as of today's recent price of $42.34.
BIB: 45.88 (-0.77)

BUYINS.NET: FXR, XIN, PRIM, HIL, MVV, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jan 25, 6:25AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Industrials/Producer Drbls AlphaDEX Fd (NYSE:FXR), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN), PRIMORIS SERVICES CORPORATION (NASDAQRIM), Hill International Inc (NYSE:HIL), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HIL: 4.38 (-0.11), PRIM: 19.22 (-0.18), MVV: 83.88 (-0.61), BIB: 45.88 (-0.77), XIN: 6.11 (-0.06), FXR: 29.28 (-0.14)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 18.5% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Jan 22, 12:48PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 18.46% as of today's recent price of $49.37.
BIB: 45.88 (-0.77)

BUYINS.NET: NOG, HTHT, BIB, KKR, HBM, JMP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Dec 18, 6:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Nordic Oil and Gas Ltd (NYSE:NOG), China Lodging Group Ltd (NASDAQ:HTHT), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), KKR & Co. L.P. (NYSE:KKR), HudBay Minerals Inc (NYSE:HBM), JMP Group Inc (NYSE:JMP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
NOG: 3.24 (-0.08), JMP: 5.52 (-0.12), BIB: 45.88 (-0.77), HBM: 4.06 (-0.13), KKR: 14.99 (+0.13), HTHT: 44.63 (-0.83)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 20

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 79

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 37

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 69

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 192

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 17

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from the 2025 Hotel Labor Costs Report for Hospitality

Updated Category News Views 191

Hotel Labor Costs and Efficiency Improvements in 2025 In a year marked by rising wages and fluctuating revenue, hotels across the United States have made significant strides in improving labor efficiency. The latest report for 2025 reveals remarkable insights into how these establishments have optimized their operations. As labor costs increased, hotels made tactical...

Continue Reading
Ritter Sport Expands Partnership with Agritask for Sustainability

Updated Category News Views 421

Ritter Sport Enhances EUDR Compliance with Agritask Ritter Sport, the renowned chocolate manufacturer, has strengthened its alliance with Agritask, a leading crop supply intelligence company. This partnership focuses on bolstering sustainability within its cocoa supply chain, especially in light of the recent European Union Deforestation Regulation (EUDR). As part of its...

Continue Reading
Investor Advocacy: Understanding Telix Pharmaceuticals' Recent Events

Updated Category News Views 240

Recent Developments at Telix Pharmaceuticals In the ever-evolving landscape of pharmaceuticals, investors constantly seek assurance regarding the stability and profitability of their chosen companies. One such company, Telix Pharmaceuticals Limited (NASDAQ: TLX), finds itself under scrutiny recently. With the increasing necessity for transparency in the healthcare sector,...

Continue Reading
Upexi's Transformative Advisory Strategy Fuels Stock Surge

Updated Category News Views 189

Upexi's Stock Performance and Strategic Direction Upexi Inc (NASDAQ:UPXI) has witnessed a remarkable rise in its stock price, showcasing a nearly 90% increase year-to-date as of the latest updates. This surge follows the company's strategic decision to form an advisory committee, announcing Arthur Hayes, a co-founder of BitMEX, as the committee's first member. This...

Continue Reading
Singapore's Economic Growth Surpasses Expectations for 2024

Updated Category News Views 324

Singapore's Economic Performance in 2024 In an impressive turn of events, Singapore's economy has shown remarkable resilience and growth, exceeding earlier forecasts. Prime Minister Lawrence Wong recently announced that the city-state achieved a 4% growth rate for its gross domestic product (GDP) in 2024, surpassing previous estimations which anticipated a moderate 3.5%...

Continue Reading